Please assess the completion status of the following clinical trial:

Trial Title: Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Adult patient undergoing ENTS surgery for resection of pituitary tumor.~* Adults \>18 years and \<80 years of age.~* English speaking and literate or able to understand the use of a pain scale.~* Body Mass Index \>19 and \<40 kg/m2~Exclusion Criteria:~* Renal failure (acute or chronic) or creatinine \>2.0~* Allergy or intolerance to acetaminophen, ibuprofen, or opioids~* Pre-operative opioid tolerance, dependence, or abuse~* Anaphylaxis to opioids~* History of peptic ulcer disease or recent gastrointestinal bleed requiring surgery~* Cirrhosis, hepatitis, liver transplant, or liver function studies out of normal range, defined as aspartate aminotransferase (AST)/alanine aminotransferase (ALT)/bilirubin\> 3x upper limit of normal range~* Subject unwilling or unable to sign informed consent for the study~* Pregnancy~* Incarcerated patients

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 79 Years
- Healthy Volunteers: f

Study Arms:
- IV Caldolor (ibuprofen) (Type: ACTIVE_COMPARATOR): Intravenous (IV) Caldolor (ibuprofen) (800mg every 8 hours) initiated during surgery and oral acetaminophen 1000mg every 6 hours initiated post-operatively and continued for the duration of the hospital stay (an expected average stay of 2 days) or 48 hours, whichever comes first. Breakthrough pain will be treated with rescue narcotics (IV morphine 2-4mg every 2 hours and oral oxycodone 5-15mg every 4 hours immediately post-operatively through discharge, an expected average stay of 2 days). Hydromorphone (IV 0.5-2mg every 2 hours and oral 2-4mg every 4 hours) will be used in patients with morphine or oxycodone allergy or intolerance.
- standard treatment group (Type: PLACEBO_COMPARATOR): IV placebo will be initiated during surgery and oral acetaminophen 1000mg every 6 hours will be initiated post-operatively and continued for the duration of the hospital stay (an expected average stay of 2 days) or 48 hours, whichever comes first. Breakthrough pain will be treated with rescue narcotics (IV morphine 2-4mg every 2 hours and oral oxycodone 5-15mg every 4 hours immediately post-operatively through discharge, an expected average stay of 2 days). Hydromorphone (IV 0.5-2mg every 2 hours and oral 2-4mg every 4 hours) will be used in patients with morphine or oxycodone allergy or intolerance.

Based on this trial design, predict the completion outcome and termination type (if applicable).